Go to deals
Healthcare

Biosynex has acquired Para’kito

Biosynex has acquired Para’kito, operated by Hong-Kong based Evergreen Land Ltd. The transaction includes assets and IP and the exclusive right to commercialize the brand in Europe, Africa and South America.

Created in 2005, Biosynex is a leading public health player in France and Europe. The group develops, manufactures and markets medical devices for screening, diagnosis and prevention. Biosynex is the French market leader in the design and distribution of rapid tests (RDT), commercialized in 90+ countries. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, resellers and department stores. In 2021, the group generated over US$400 million of sales.

Launched in 2008, Para’kito is the leading European brand in the prevention and care of mosquito bites. The company provides a complete range of anti-mosquito bracelets and sprays based on 100% natural formulas, with a proprietary technology, and distributed via two channels: pharmacies and e-commerce. Para’kito is present in more than 30 countries and supplies 5,000+ pharmacies in France. In 2021, the brand generated over US$7 million of sales in Europe.

Oaklins’ team in France acted as M&A advisor to Biosynex in this transaction.

Service
M&A buy-side
Parties

Talk to the deal team

 Ludovic  Beaulieu

Ludovic Beaulieu

Partner

Paris, France
Oaklins France
 Loris  Gabrielian

Loris Gabrielian

Associate

Paris, France
Oaklins France
 Quentin  Boissinot

Quentin Boissinot

Analyst

Paris, France
Oaklins France

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more
Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes
Private Equity | Healthcare

Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes

Groupe Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes from the funding family.

Learn more
Converge International has acquired HeadUp Labs
Healthcare

Converge International has acquired HeadUp Labs

The shareholders of HeadUp Labs have sold the company to Converge International. The acquisition of HeadUp is a strong fit with Converge’s digital product growth strategy, and has the potential to create a fully integrated and holistic preventative workplace mental health, safety, wellbeing and engagement product.

Learn more